Delphi Genetics SA-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Delphi Genetics SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013085
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Delphi Genetics SA (Delphi Genetics) is a genetic engineering and bioproductions company that develops products and technologies for gene cloning and protein expression in bacteria. The company offers services which include gene synthesis, DNA cloning and mutagenesis Plasmid production, protein immunization, customized recombinant protein production, Q-PCR analysis among others. The company’s products include PCR cloning, staby cloning, protein expression, vector adaptation, DNA immunization, reagents and competent cells. It also develops products based on a bacterial poison antidote genes technology. The company distributes its products through its distribution networks in the US, Germany, Austria, Singapore, Malaysia, Indonesia and Japan. Delphi Genetics is headquartered in Charleroi, Belgium.

Delphi Genetics SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Delphi Genetics SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Delphi Genetics SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Delphi Genetics SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Delphi Genetics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Delphi Genetics SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Delphi Genetics SA, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Delphi Genetics Raises Funds through Venture Financing 10
Partnerships 11
Delphi Genetics Enters into Agreement with Avaxia Biologics 11
Alma Bio Therapeutics and Delphi Genetics Extend Agreement 12
Licensing Agreements 13
Delphi Genetics Enters into Licensing Agreement for StabyExpress Technology 13
Delphi Genetics Enters Into Licensing Agreement With Merck For StabyExpress Technology 14
Delphi Genetics SA – Key Competitors 15
Delphi Genetics SA – Key Employees 16
Delphi Genetics SA – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Delphi Genetics SA, Pharmaceuticals & Healthcare, Key Facts 2
Delphi Genetics SA, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Delphi Genetics SA, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Delphi Genetics SA, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Delphi Genetics SA, Deals By Therapy Area, 2011 to YTD 2017 8
Delphi Genetics SA, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Delphi Genetics Raises Funds through Venture Financing 10
Delphi Genetics Enters into Agreement with Avaxia Biologics 11
Alma Bio Therapeutics and Delphi Genetics Extend Agreement 12
Delphi Genetics Enters into Licensing Agreement for StabyExpress Technology 13
Delphi Genetics Enters Into Licensing Agreement With Merck For StabyExpress Technology 14
Delphi Genetics SA, Key Competitors 15
Delphi Genetics SA, Key Employees 16

★海外企業調査レポート[Delphi Genetics SA-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Isetan Mitsukoshi Holdings Ltd.:企業の戦略・SWOT・財務分析
    Isetan Mitsukoshi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Isetan Mitsukoshi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Terna Energy SA (TENERGY):企業の財務・戦略的SWOT分析
    Terna Energy SA (TENERGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Fossil Group, Inc.:企業の戦略・SWOT・財務情報
    Fossil Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Fossil Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Northern Sun Mining Corp:企業の戦略・SWOT・財務分析
    Northern Sun Mining Corp - Strategy, SWOT and Corporate Finance Report Summary Northern Sun Mining Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Congenica Ltd-医療機器分野:企業M&A・提携分析
    Summary Congenica Ltd (Congenica) is a biotechnology company that offers research and experimental development on biotechnology. The company’s technology SAPIENTIA, is used to personalize patient care through accurate diagnoses, support clinical trials, and drug development. It offers services such …
  • Ngai Hing Hong Co Ltd (1047):企業の財務・戦略的SWOT分析
    Ngai Hing Hong Co Ltd (1047) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sterling Bank Plc
    Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report Summary Sterling Bank Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Primark Stores Ltd:企業の戦略・SWOT・財務情報
    Primark Stores Ltd - Strategy, SWOT and Corporate Finance Report Summary Primark Stores Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Barbara Ann Karmanos Cancer Institute-製薬・医療分野:企業M&A・提携分析
    Summary Barbara Ann Karmanos Cancer Institute (Karmanos), a subsidiary of McLaren Health Care Corp is a healthcare institute that provides patient care and educational services. The institute offers patient care for the prevention, early detection, treatment and eventual eradication of cancer. Its c …
  • Pampa Energia SA (PAMP):石油・ガス:M&Aディール及び事業提携情報
    Summary Pampa Energia SA (Pampa) is an independent integrated energy company. It generates, distributes and transmits electricity; and explores and produces, refines oil and gas, and petrochemicals and commercializes and transports them. The company produces electricity using coal, wind, hydro, and …
  • Landesbank Baden-Wurttemberg:企業のM&A・事業提携・投資動向
    Landesbank Baden-Wurttemberg - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Landesbank Baden-Wurttemberg Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Wright Medical Group NV (WMGI):医療機器:M&Aディール及び事業提携情報
    Summary Wright Medical Group NV (Wright) is a medical device company which focuses on extremity and biologic solutions. The company designs, manufactures and markets reconstructive joint devices including extremity implants for the shoulder, elbow, foot, ankle and hand; foot and ankle products. It a …
  • Berjaya Corporation Berhad:企業の戦略・SWOT・財務情報
    Berjaya Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Berjaya Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • ProteoMediX AG:医療機器:M&Aディール及び事業提携情報
    Summary ProteoMediX AG (ProteoMediX) is a medical diagnostic company that identifies and develops novel biomarkers for the early detection of cancer and the personalized treatment. The company develops non-invasive diagnostic tests for the detection, prognosis, stratification, and therapy-selection …
  • Emgesa SA ESP:企業の戦略的SWOT分析
    Emgesa SA ESP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • The Yomiuri Shimbun:企業の戦略的SWOT分析
    The Yomiuri Shimbun - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • S Chand And Company Limited (SCHAND):企業の財務・戦略的SWOT分析
    S Chand And Company Limited (SCHAND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • National Gypsum Co:企業の戦略・SWOT・財務分析
    National Gypsum Co - Strategy, SWOT and Corporate Finance Report Summary National Gypsum Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Aravive Inc (VSAR):企業の財務・戦略的SWOT分析
    Summary Aravive Inc(Aravive) formerly known as Versartis Inc, is a biopharmaceutical company that develops, manufactures and commercializes medicines for the treatment of endocrine disorders. The company’s lead product candidate include somavaratan (VRS-317) is a recombinant human growth hormone (GH …
  • West Japan Railway Company (9021):企業の財務・戦略的SWOT分析
    West Japan Railway Company (9021) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆